California Public Employees Retirement System boosted its position in Omega Healthcare Investors Inc (NYSE:OHI) by 32.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 465,755 shares of the real estate investment trust’s stock after buying an additional 113,234 shares during the quarter. California Public Employees Retirement System owned approximately 0.21% of Omega Healthcare Investors worth $19,464,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
A number of other institutional investors and hedge funds have also recently modified their holdings of OHI. Pensionfund DSM Netherlands purchased a new stake in Omega Healthcare Investors in the second quarter worth approximately $1,764,000. Pensionfund Sabic purchased a new stake in Omega Healthcare Investors in the second quarter worth approximately $735,000. Eii Capital Management Inc. boosted its stake in Omega Healthcare Investors by 3.0% in the second quarter. Eii Capital Management Inc. now owns 20,676 shares of the real estate investment trust’s stock worth $760,000 after buying an additional 599 shares in the last quarter. Retirement Systems of Alabama boosted its stake in Omega Healthcare Investors by 2.8% in the second quarter. Retirement Systems of Alabama now owns 482,979 shares of the real estate investment trust’s stock worth $17,749,000 after buying an additional 13,171 shares in the last quarter. Finally, RPG Investment Advisory LLC boosted its stake in Omega Healthcare Investors by 74.0% in the second quarter. RPG Investment Advisory LLC now owns 235,247 shares of the real estate investment trust’s stock worth $8,640,000 after buying an additional 100,013 shares in the last quarter. 69.27% of the stock is owned by institutional investors and hedge funds.
NYSE:OHI opened at $41.07 on Friday. The firm has a market cap of $9.25 billion, a PE ratio of 13.51, a price-to-earnings-growth ratio of 5.76 and a beta of 0.33. Omega Healthcare Investors Inc has a fifty-two week low of $33.39 and a fifty-two week high of $45.01. The company has a debt-to-equity ratio of 1.17, a quick ratio of 2.78 and a current ratio of 2.78. The business has a 50 day moving average price of $42.82 and a 200-day moving average price of $38.90.
Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings data on Tuesday, November 5th. The real estate investment trust reported $0.63 earnings per share for the quarter, missing analysts’ consensus estimates of $0.73 by ($0.10). The company had revenue of $199.00 million for the quarter, compared to analysts’ expectations of $194.26 million. Omega Healthcare Investors had a net margin of 38.12% and a return on equity of 8.87%. The business’s revenue for the quarter was up 3.5% compared to the same quarter last year. During the same period last year, the company posted $0.77 EPS. Research analysts predict that Omega Healthcare Investors Inc will post 2.95 EPS for the current year.
The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Thursday, October 31st will be paid a dividend of $0.67 per share. This represents a $2.68 dividend on an annualized basis and a dividend yield of 6.53%. The ex-dividend date is Wednesday, October 30th. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.66. Omega Healthcare Investors’s dividend payout ratio is 88.16%.
OHI has been the subject of several research reports. Berenberg Bank initiated coverage on Omega Healthcare Investors in a research note on Thursday, September 12th. They issued a “buy” rating and a $47.00 target price for the company. Raymond James lowered Omega Healthcare Investors from a “strong-buy” rating to a “market perform” rating in a research note on Monday, October 21st. Zacks Investment Research lowered Omega Healthcare Investors from a “hold” rating to a “sell” rating in a research note on Wednesday. Wells Fargo & Co upped their target price on Omega Healthcare Investors from $36.00 to $40.00 and gave the stock a “market perform” rating in a research note on Friday, August 23rd. Finally, Bank of America reissued a “buy” rating and set a $44.50 price objective on shares of Omega Healthcare Investors in a research note on Monday, October 14th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $41.98.
In other news, COO Daniel J. Booth sold 20,000 shares of the stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $40.24, for a total transaction of $804,800.00. Following the completion of the sale, the chief operating officer now owns 178,241 shares of the company’s stock, valued at $7,172,417.84. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, CFO Robert O. Stephenson sold 10,000 shares of the stock in a transaction that occurred on Friday, August 16th. The shares were sold at an average price of $39.00, for a total value of $390,000.00. The disclosure for this sale can be found here. In the last three months, insiders have sold 45,500 shares of company stock valued at $1,822,300. Insiders own 1.16% of the company’s stock.
Omega Healthcare Investors Profile
Omega is a real estate investment trust that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the US, as well as in the UK.
Featured Article: Average Daily Trade Volume – What You Need to Know
Receive News & Ratings for Omega Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Omega Healthcare Investors and related companies with MarketBeat.com's FREE daily email newsletter.